Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Changes in the pattern reversal visual evoked potentials in myasthenia gravis

F Fotiou1, D Papakostopoulos, P Hamlatzis

  • 1Department of Neurology, Medical School, Aristotelian University of Thessaloniki, AHEPA Hospital, Greece.

Electromyography and Clinical Neurophysiology
|April 1, 1994
PubMed
Summary

Myasthenia Gravis (MG) patients show impaired central nervous system cholinergic transmission, evidenced by abnormal PR-VEPs. Pyridostigmine treatment improved these visual pathway responses, suggesting PR-VEPs can monitor treatment efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do depressive patients with family history of dementia constitute a separate group? A case report study.

International journal of psychiatry in clinical practice·2014
Same author

Evaluation of pupil mobility in patients with myasthenia gravis.

Electromyography and clinical neurophysiology·2008
Same author

Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods?

Journal of affective disorders·2006
Same author

Changes in the pupil reflex arc in depressive patients.

Journal of affective disorders·2005
Same author

Relationship among Dexamethasone Suppression Test, personality disorders and stressful life events in clinical subtypes of major depression: An exploratory study.

Annals of general hospital psychiatry·2004
Same author

Relation of personality disorders to subtypes of major depression according both to DSM-IV and ICD-10.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2002

Area of Science:

  • Neuroscience
  • Clinical Neurology
  • Ophthalmology

Background:

  • Myasthenia Gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
  • Cholinergic pathways in the Central Nervous System (CNS) may be implicated in MG.
  • Assessing CNS involvement in MG requires reliable neurophysiological markers.

Purpose of the Study:

  • To investigate potential impairment of cholinergic transmission in the CNS of MG patients.
  • To evaluate the effectiveness of pyridostigmine treatment on CNS cholinergic function in MG.
  • To determine the utility of Pattern Reversal Visual Evoked Potentials (PR-VEPs) in studying MG's central effects.

Main Methods:

  • PR-VEPs were recorded in 11 newly diagnosed MG patients before and after pyridostigmine treatment.

Related Experiment Videos

  • Data from MG patients were compared to 10 healthy control subjects.
  • Visual evoked potentials were assessed for P100 amplitude and latency.

    • Main Results:

    • MG patients exhibited significantly lower P100 amplitude and longer latency in PR-VEPs compared to controls.
    • Pyridostigmine treatment led to a significant improvement in P100 amplitude in MG patients.
    • PR-VEPs demonstrated neurophysiological evidence of altered cholinergic transmission in the CNS.

    Conclusions:

    • Cholinergic transmission in the CNS appears impaired in Myasthenia Gravis patients.
    • PR-VEPs provide a non-invasive method to assess central nervous system effects in MG.
    • PR-VEPs may serve as a tool to monitor the efficacy of pyridostigmine therapy in MG.